IP Library › Granted Patent US 10,307,468
Granted Patent B2
US 10,307,468 · App. 15/306,006 · Granted Jun 4, 2019

Manufacture of di-chain recombinant

Inventors: Shilpa Palan (Abingdon, GB); Sai Man Liu (Abingdon, GB); Gavin Stephen Hackett (Abingdon, GB)
Assignee: IPSEN BIOINNOVATION LIMITED
A61K38/4893A61K47/02A61K47/26C12N9/6489C12P21/06C12Y304/24069Y02A50/469
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,307,468
App. No.
15/306,006
Granted
Jun 4, 2019
Kind
B2
Abstract

Methods for producing di-chain BoNT/A from single chain BoNT/A using Lys-C followed by purification using a hydrophobic surface.

Claims (13)

1. A method for producing soluble di-chain BoNT/A protein, said method comprising:

a) providing a soluble single-chain BoNT/A protein;

b) contacting said BoNT/A protein with endoproteinase Lys-C (Lys-C) in solution; and

c) separating the soluble BoNT/A protein from the Lys-C by contacting the solution containing soluble BoNT/A protein and Lys-C with a hydrophobic surface, wherein the soluble BoNT/A protein binds with preference to the hydrophobic surface.

2. The method according to claim 1 , wherein the soluble single-chain BoNT/A protein is produced (i) in a host cell, by expressing a nucleic acid encoding said single-chain BoNT/A protein in an expression system; or (ii) in an in vitro expression system.

3. The method according to claim 2 , wherein the host cell is a bacterial host cell and the expression system is a bacterial expression system.

4. The method according to claim 3 , wherein the bacterial expression system is an E. coli expression system and the host cell is an E. coli cell.

5. The method according to claim 2 , wherein said soluble single-chain BoNT/A protein is expressed in the cytoplasm of said host cell.

6. The method according to claim 2 , wherein said soluble single-chain BoNT/A protein is expressed at a level of at least 5 mg/L.

7. The method according to claim 2 , comprising lysis of the bacterial or E. coli host cell to provide a bacterial or E. coli host cell homogenate containing said soluble single-chain BoNT/A protein.

8. The method according to claim 1 , wherein the hydrophobic surface is an inert matrix to which a ligand consisting of aryl or alkyl groups is attached.

9. The method according to claim 8 , wherein the ligand is selected from the group consisting of: butyl, phenyl and octyl ligands.

10. The method according to claim 9 , wherein a high performance hydrophobic surface is used.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2017
From: PALAN, SHILPA; LIU, SAI MAN; HACKETT, GAVIN STEPHEN
To: IPSEN BIOINNOVATION LTD.
Reel/Frame 041136/0780 →
Priority Claims (1)
GB 1407525.3 · Apr 29, 2014 · national
Continuity (1)
Related Publication 20180117128A1 · May 3, 2018
Cited By (2)
US 12,409,211 US 12,421,284